김인희
#간질환#간염#간경변증#간암#간담도 질환#소화기 질환
|
학력
- 전북대학교 의과대학 졸업
- 전북대학교 의학석사
- 전북대학교 의학박사
- 전북대학교 의학석사
- 전북대학교 의학박사
경력
- 대한간학회 춘계학술대회 Best Presentation Award, Plenary Session(2012)
- 미국 University of California San Diego, Health Sciences 방문교수(2014-2015)
- 한국의약품안전관리원 DUR 분과위원(2018-현재)
- 한국의료분쟁조정중재원 의료사고 감정단 자문위원(2018-현재)
- 국제논문 검토위원: Gut Liver, World Journal of Gastroenterology
- 전북대학교 의과대학 교육부학장(2018-2019)
- 미국 University of California San Diego, Health Sciences 방문교수(2014-2015)
- 한국의약품안전관리원 DUR 분과위원(2018-현재)
- 한국의료분쟁조정중재원 의료사고 감정단 자문위원(2018-현재)
- 국제논문 검토위원: Gut Liver, World Journal of Gastroenterology
- 전북대학교 의과대학 교육부학장(2018-2019)
논문
- 1. Epidemiological and Clinical Characteristics of Hepatitis C Virus Infection in South Korea from 2007 to 2017: A Prospective Multicenter Cohort Study. Gut Liver. 2019 Jun 3. doi: 10.5009/gnl19005. [Epub ahead of print]
- 2. Treatment Outcome and Renal Safety of 3-Year Tenofovir Disoproxil Fumarate Therapy in Chronic Hepatitis B Patients with Preserved Glomerular Filtration Rate. Gut Liver 2019 Jan 15;13(1):93-103.
- 3. Chronic Hepatitis B Infection Is Significantly Associated with Chronic Kidney Disease: a Population-based, Matched Case-control Study. J Korean Med Sci 2018 Sep 12;33(42):e264.
- 4. A Novel Model to Predict 1-Month Risk of Transplant or Death in Hepatitis A-Related Acute Liver Failure. Hepatology 2018 Sep 8. doi: 10.1002/hep.30262. [Epub ahead of print].
- 5. Switching to tenofovir vs continuing entecavir for hepatitis B virus with partial virologic response to entecavir: a randomized controlled trial. J Viral Hepat 2018 Nov;25(11):1321-1330.
- 6. Factors Associated with Health-Related Quality of Life in Korean Patients with Chronic Hepatitis C Infection Using the SF-36 and EQ-5D. Gut Liver 2018 Jul 15;12(4):440-448.
- 7. Effects of branched-chain amino acids (BCAAs) on the progression of advanced liver disease: A Korean nationwide, multicenter, retrospective, observational, cohort study. Medicine (Baltimore) 2017 Jun;96(24):e6580.
- 8. Final Report of Unmet Needs of Interferon-Based Therapy for Chronic Hepatitis C in Korea: Basis for Moving into the Direct-Acting Antiviral Era. Gut Liver 2017 Jul 15;11(4):543-550.
- 9. Prevalence and Incidence of Depression during Interferon-Based Antiviral Therapy in Chronic Hepatitis C Patients in the Republic of Korea. Gut Liver 2017 May 15;11(3):426-433.
- 10. The Potential Role of Elk-3/Egr-1 Signaling Pathway in the Epithelial-Mesenchymal Transition during Liver Fibrosis. Gut Liver 2017 Jan 15;11(1):11-12.
- 11. 3-Dimensional liver volume assessment in patients with hepatitis B virus-related liver cirrhosis during long-term oral nucleos(t)ide analogues therapy. World J Gastroenterol 2017 Jan 14;23(2):297-305.
- 12. An Observational, Multicenter, Cohort Study Evaluating the Antiviral Efficacy and Safety in Korean Patients With Chronic Hepatitis B Receiving Pegylated Interferon-alpha 2a (Pegasys): TRACES Study. Medicine (Baltimore) 2016 Apr;95(14):e3026.
- 13. The clinical outcomes of chronic hepatitis C in South Korea: A prospective, multicenter cohort study. Medicine (Baltimore) 2016 Aug;95(35):e4594.
- 14. Treatment rate and factors related to interferon-based treatment initiation for chronic hepatitis C in South Korea. J Med Virol 2016 Feb;88(2):275-81.
- 15. Aging increases the susceptibility of hepatic inflammation, liver fibrosis and aging in response to high-fat diet in mice. Age (Dordr) 2016 Aug;38(4):291-302.
- 16. Aging and liver disease. Curr Opin Gastroenterol 2015 May ;31(3):184-91.
- 17. Management of entecavir-resistant chronic hepatitis B with adefovir-based combination therapies. World J Gastroenterol 2015 Oct 14;21(38):10874-82.
- 18. A prospective cohort study on the outcomes of hepatitis C virus-related cirrhosis in South Korea. J Gastroenterol Hepatol 2015 Aug;30(8):1281-7.
- 19. Accuracy of transient elastography in assessing liver fibrosis in chronic viral hepatitis: A multicentre, retrospective study. Liver Int 2015 Oct;35(10):2246-55.
- 20. Clinical characteristics and prognostic impact of bacterial infection in hospitalized patients with alcoholic liver disease. J Korean Med Sci 2015 May; 30(5): 598-605.
- 21. Disease Progression in Chronic Hepatitis B Patients under Long-term Antiviral Therapy. Gut Liver 2015 May; 9(3): 395-404.
- 22. The types of hepatic myofibroblasts contributing to liver fibrosis of different etiologies. Frontiers in Pharmacology 2014 Jul 22;5:167.
- 23. Pentoxifylline versus corticosteroid to treat severe alcoholic hepatitis: A randomised, noninferiority, open trial. J Hepatol 2014 Oct;61(4):792-8.
- 2. Treatment Outcome and Renal Safety of 3-Year Tenofovir Disoproxil Fumarate Therapy in Chronic Hepatitis B Patients with Preserved Glomerular Filtration Rate. Gut Liver 2019 Jan 15;13(1):93-103.
- 3. Chronic Hepatitis B Infection Is Significantly Associated with Chronic Kidney Disease: a Population-based, Matched Case-control Study. J Korean Med Sci 2018 Sep 12;33(42):e264.
- 4. A Novel Model to Predict 1-Month Risk of Transplant or Death in Hepatitis A-Related Acute Liver Failure. Hepatology 2018 Sep 8. doi: 10.1002/hep.30262. [Epub ahead of print].
- 5. Switching to tenofovir vs continuing entecavir for hepatitis B virus with partial virologic response to entecavir: a randomized controlled trial. J Viral Hepat 2018 Nov;25(11):1321-1330.
- 6. Factors Associated with Health-Related Quality of Life in Korean Patients with Chronic Hepatitis C Infection Using the SF-36 and EQ-5D. Gut Liver 2018 Jul 15;12(4):440-448.
- 7. Effects of branched-chain amino acids (BCAAs) on the progression of advanced liver disease: A Korean nationwide, multicenter, retrospective, observational, cohort study. Medicine (Baltimore) 2017 Jun;96(24):e6580.
- 8. Final Report of Unmet Needs of Interferon-Based Therapy for Chronic Hepatitis C in Korea: Basis for Moving into the Direct-Acting Antiviral Era. Gut Liver 2017 Jul 15;11(4):543-550.
- 9. Prevalence and Incidence of Depression during Interferon-Based Antiviral Therapy in Chronic Hepatitis C Patients in the Republic of Korea. Gut Liver 2017 May 15;11(3):426-433.
- 10. The Potential Role of Elk-3/Egr-1 Signaling Pathway in the Epithelial-Mesenchymal Transition during Liver Fibrosis. Gut Liver 2017 Jan 15;11(1):11-12.
- 11. 3-Dimensional liver volume assessment in patients with hepatitis B virus-related liver cirrhosis during long-term oral nucleos(t)ide analogues therapy. World J Gastroenterol 2017 Jan 14;23(2):297-305.
- 12. An Observational, Multicenter, Cohort Study Evaluating the Antiviral Efficacy and Safety in Korean Patients With Chronic Hepatitis B Receiving Pegylated Interferon-alpha 2a (Pegasys): TRACES Study. Medicine (Baltimore) 2016 Apr;95(14):e3026.
- 13. The clinical outcomes of chronic hepatitis C in South Korea: A prospective, multicenter cohort study. Medicine (Baltimore) 2016 Aug;95(35):e4594.
- 14. Treatment rate and factors related to interferon-based treatment initiation for chronic hepatitis C in South Korea. J Med Virol 2016 Feb;88(2):275-81.
- 15. Aging increases the susceptibility of hepatic inflammation, liver fibrosis and aging in response to high-fat diet in mice. Age (Dordr) 2016 Aug;38(4):291-302.
- 16. Aging and liver disease. Curr Opin Gastroenterol 2015 May ;31(3):184-91.
- 17. Management of entecavir-resistant chronic hepatitis B with adefovir-based combination therapies. World J Gastroenterol 2015 Oct 14;21(38):10874-82.
- 18. A prospective cohort study on the outcomes of hepatitis C virus-related cirrhosis in South Korea. J Gastroenterol Hepatol 2015 Aug;30(8):1281-7.
- 19. Accuracy of transient elastography in assessing liver fibrosis in chronic viral hepatitis: A multicentre, retrospective study. Liver Int 2015 Oct;35(10):2246-55.
- 20. Clinical characteristics and prognostic impact of bacterial infection in hospitalized patients with alcoholic liver disease. J Korean Med Sci 2015 May; 30(5): 598-605.
- 21. Disease Progression in Chronic Hepatitis B Patients under Long-term Antiviral Therapy. Gut Liver 2015 May; 9(3): 395-404.
- 22. The types of hepatic myofibroblasts contributing to liver fibrosis of different etiologies. Frontiers in Pharmacology 2014 Jul 22;5:167.
- 23. Pentoxifylline versus corticosteroid to treat severe alcoholic hepatitis: A randomised, noninferiority, open trial. J Hepatol 2014 Oct;61(4):792-8.
저서
저서 내용이 없습니다.
보도자료
전북대병원, 김인희 교수 세계인명사전 오른다
http://v.media.daum.net/v/20131007155107951?f=o
전북대병원 소화기내과 김형일 전임의 '우수 구연상' 수상
https://cp.news.search.daum.net/p/5825593
A형 간염 확산추세, 전북도 대비해야
https://cp.news.search.daum.net/p/79123355
http://v.media.daum.net/v/20131007155107951?f=o
전북대병원 소화기내과 김형일 전임의 '우수 구연상' 수상
https://cp.news.search.daum.net/p/5825593
A형 간염 확산추세, 전북도 대비해야
https://cp.news.search.daum.net/p/79123355
포스팅
포스팅 내용이 없습니다.
영상자료
영상자료 내용이 없습니다.
발표자료
발표자료 내용이 없습니다.